Galileo Health vs Hims & Hers

Side-by-side comparison of AI visibility scores, market position, and capabilities

Hims & Hers leads in AI visibility (86 vs 54)
Galileo Health logo

Galileo Health

ChallengerHealthcare

Virtual Primary Care & Telehealth

Galileo Health is a 50-state virtual primary care practice offering 24/7 text and video access to board-certified doctors for $35/visit or $13/month membership; serves health plans, employers, and Fortune 500 organizations.

AI VisibilityBeta
Overall Score
C54
Category Rank
#174 of 596
AI Consensus
87%
Trend
stable
Per Platform
ChatGPT
57
Perplexity
53
Gemini
57

About

Galileo Health is a technology-driven medical practice that provides comprehensive primary care, multi-specialty, urgent, behavioral health, and chronic disease management services through a combination of virtual and in-clinic care. Founded in 2018 and headquartered in New York, Galileo operates across all 50 US states and is staffed by teams of board-certified physicians and nurse practitioners available 24/7 via the company''s mobile app. The platform is designed to serve both individual consumers and institutional partners — including regional and national health plans, employers, and Fortune 500 organizations — as a population health management solution.

Full profile
Hims & Hers logo

Hims & Hers

EmergingHealthcare

Telehealth Pharmacy

Consumer telehealth platform with Q3 2025 revenue of $599M (+49% YoY); 2.47M subscribers; 2025 guidance $2.3-2.4B; acquiring ZAVA for European expansion; GLP-1 weight loss, hair, and sexual health treatments shipped directly to subscribers.

AI VisibilityBeta
Overall Score
A86
Category Rank
#8 of 596
AI Consensus
79%
Trend
stable
Per Platform
ChatGPT
88
Perplexity
92
Gemini
83

About

Hims & Hers is a consumer telehealth and pharmacy platform founded in 2017 in San Francisco by Andrew Dudum, built on the mission of making high-quality healthcare affordable and stigma-free for conditions that people historically avoided treating due to embarrassment, cost, or access barriers. The platform's core technology combines a direct-to-consumer digital health interface with an integrated pharmacy network, enabling patients to complete asynchronous or synchronous consultations with licensed clinicians and receive prescription treatments — including compounded medications — delivered directly to their homes.\n\nHims & Hers serves patients across sexual health, hair loss, mental health, dermatology, and weight management. The company's expansion into GLP-1 compounded weight loss medications has been a significant growth catalyst, capitalizing on surging consumer demand for semaglutide and tirzepatide alternatives during periods of branded drug shortages. With 2.47 million subscribers and a subscription-centric business model, the platform generates predictable recurring revenue from patients on ongoing treatment protocols. The company's 2025 acquisition of ZAVA expands its addressable market into European telehealth markets.\n\nHims & Hers reported Q3 revenue of $599 million, a 49% year-over-year increase, and issued full-year 2025 guidance of $2.3 to $2.4 billion — a scale that makes it one of the largest consumer telehealth companies in the world. The company's ability to compound subscriber growth with expanding treatment categories and international expansion through ZAVA provides multiple vectors for continued revenue acceleration. As healthcare consumerization intensifies and patients increasingly manage chronic conditions through digital-first platforms, Hims & Hers' brand recognition, integrated pharmacy infrastructure, and subscription model give it a durable position in consumer health.

Full profile

AI Visibility Head-to-Head

54
Overall Score
86
#174
Category Rank
#8
87
AI Consensus
79
stable
Trend
stable
57
ChatGPT
88
53
Perplexity
92
57
Gemini
83
56
Claude
90
53
Grok
89

Key Details

Category
Virtual Primary Care & Telehealth
Telehealth Pharmacy
Tier
Challenger
Emerging
Entity Type
brand
brand

Capabilities & Ecosystem

Capabilities

Only Hims & Hers
Telehealth Pharmacy

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.